The EID Advantage: Why Publish in Emerging Infectious Diseases?

Since its founding in 1995, EID has become one of the world's most trusted and cited infectious disease journals. Authors choose EID to publish their work for several reasons.

Free and Open Access for Authors and Readers

• EID is a green open-access, online journal with no fees for authors or readers.
• Publishing in EID is free—no submission fees, page charges, costs for corrections, or other fees. 
• All content published by EID is immediately and freely available, without embargo, to anyone in the world with Internet access. 
• All issues are deposited upon publication in PubMed Central and in the Directory of Open Access Journals. 

Acceptance and Publication Statistics

• From year to year, EID typically receives approximately 2,000 submissions annually and accepts approximately 25% of submitted articles for publication. A small number of published manuscripts were invited. 
• EID published 550 articles in 2022, 584 in 2021, 638 in 2020, 523 in 2019, and 521 in 2018.

Circulation and Impact

• More than 65,000 persons subscribe to EID's monthly table of content email alerts, and each of the 25 topical email alerts has from 12,000 to 50,000 subscribers.
• EID’s current Journal Impact Factor score is 11.8, 4th among the world's open-access infectious disease journals and 10th among 96 tracked infectious disease journals. 
• For 2023, EID's Google Scholar h5-index was 109 and its h5-median was 210. EID ranked 2nd among the top 20 Epidemiology publications and 6th among the top 20 Communicable Diseases publications, and was 2nd among open-access journals in both categories. 

Supported by the U.S. Centers for Disease Control and Prevention

• CDC is the sole funder of the journal, and EID contains no advertising. The journal’s peer review, editorial, and publishing processes and decisions are all conducted independently.
• EID is the scientific communications component of CDC’s efforts against the threat of emerging and reemerging infectious diseases. 
• Even as it addresses CDC's own interest in the elusive, continuous, evolving, and global nature of these infections, the journal relies on a broad international authorship base outside CDC and is rigorously peer-reviewed by external independent reviewers from all over the world. 

Early Release Policy

• All final-accepted EID articles are typically posted online as early release articles after initial copyediting. (Early release articles are not considered final versions.)
• Later, all early release articles are finalized and compiled as part of a formal online-published monthly issue.  
• The Editor in Chief selects certain manuscripts with urgent public health importance for expedited early release publication.

Distinguished Editors and Peer Reviewers 

• EID engages expert physicians and scientists as associate editors and editorial board members.
• Each year, distinguished experts around the world serve as peer reviewers on manuscripts submitted to the journal. 

Professional Staff Support

• All members of the journal’s staff are dedicated to assisting reviewers and authors.
• Administrative staff help with ScholarOne submissions and accounts.
• EID’s editorial team members work with authors on manuscripts and provide guidance throughout the editing and proofing process.
• The journal’s graphics experts provide authors advice on images, figures, and tables, develop final versions of graphical content, and offer guidance on 508 compliance. 
• EID’s communications staff post article titles on social media, work with authors to amplify their own social media postings, and create podcasts for selected articles.

Podcasts and CME

• A small number of key articles in each monthly issue are developed into EID Podcasts, which now total more than 420. All of EID’s podcasts are freely available from the Internet.
• Two articles from each issue are selected to provide free continuing education credit for readers. EID’s CME article credits are provided by Medscape, LLC, which is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC).

Social Media

• EID’s Communications staff maintains and promotes the journal's presence on Facebook, Twitter, Instagram, and LinkedIn. 
• To date, 27 articles published in EID are ranked in the top 5,000 of the more than 24,00,000 research outputs ever tracked by Altmetric, and more than 1,350 EID articles have attention scores ranked in the top 5%.

Supplements

• In addition to publishing 12 regular monthly issues per year, EID produces occasional supplements. Those issues focus on specific topics, which are nominated by the supplement organizers/guest editors and are deemed by EID editors to be within the scope of the journal and of interest to the journal’s readership. 
• Although there is a cost to supplement organizers for publishing with EID, there are no author fees. All content is freely available to readers as soon as it is published. 
• To see examples, visit the 2022 issue titled CDC and Global Health Systems and Programs During the COVID-19 Pandemic and the 2017 issue titled Global Health Security. 
• To propose a supplement, prospective organizers should send a brief proposal to eideditor@cdc.gov.